StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mylan (MYL) Reports FDA Approval of Heparin Sodium Injection
December 1, 2017 10:53 AM
Mylan N.V. (NASDAQ: MYL), a global pharmaceutical company, today announced it has received final approval from the U.S. Food ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
Mylan (MYL) and Aspen Report Launch of Generic Busulfex Injection
December 4, 2017 7:36 AM
FDA Approval of Heparin Sodium Injection Continues to Demonstrate Mylan's Deep Expertise in Developing Complex Products
December 1, 2017 10:50 AM
Mylan's (MYL) Biosimilar to Roche's Herceptin Wins FDA Approval
December 1, 2017 10:46 AM
